Hubei Jumpcan Pharmaceutical Co Ltd (600566.SS)
600566.SS on Shanghai Stock Exchange
33.86CNY
14 Dec 2018
33.86CNY
14 Dec 2018
Change (% chg)
¥-1.12 (-3.20%)
¥-1.12 (-3.20%)
Prev Close
¥34.98
¥34.98
Open
¥34.62
¥34.62
Day's High
¥35.19
¥35.19
Day's Low
¥33.50
¥33.50
Volume
6,071,496
6,071,496
Avg. Vol
4,294,509
4,294,509
52-wk High
¥54.97
¥54.97
52-wk Low
¥32.80
¥32.80
Revenue & Earnings Per Share
| Revenue* | Earnings Per Share** | ||
|---|---|---|---|
| FY 2018 | Sep '18 | 1,740.26 | 0.570 |
| Jun '18 | 1,676.12 | 0.464 | |
| Mar '18 | 2,127.61 | 0.574 | |
| FY 2017 | Dec '17 | 1,428.39 | 0.390 |
| Sep '17 | 1,403.45 | 0.402 | |
| Jun '17 | 1,405.36 | 0.360 | |
| Mar '17 | 1,404.81 | 0.359 | |
| FY 2016 | Dec '16 | 1,171.42 | 0.319 |
| Sep '16 | 1,152.67 | 0.292 | |
| Jun '16 | 1,197.19 | 0.292 | |
| Mar '16 | 1,156.62 | 0.268 |
*Note: Units in Millions ofRenminbi
**Note: Units in Renminbi
Consensus Estimates Analysis
| # of Estimates | Mean | High | Low | 1 Year Ago | |
|---|---|---|---|---|---|
| SALES (in millions) | |||||
| Year Ending Dec-18 | 7 | 7,195.80 | 7,617.00 | 6,919.32 | 6,949.96 |
| Year Ending Dec-19 | 7 | 8,782.49 | 9,902.00 | 8,295.43 | 8,435.74 |
| Earnings (per share) | |||||
| Year Ending Dec-18 | 7 | 2.05 | 2.11 | 2.00 | 1.84 |
| Year Ending Dec-19 | 7 | 2.61 | 2.97 | 2.47 | 2.32 |
Sales and Profit Figures in China Yuan Renminbi (CNY);
Valuation Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| P/E Ratio (TTM) | 27.73 | 31.13 | 34.39 | |
| P/E High - Last 5 Yrs. | 31.48 | 40.59 | 46.24 | |
| P/E Low - Last 5 Yrs. | 17.01 | 23.99 | 24.59 | |
| Beta | 0.47 | 0.91 | 0.91 | |
| Price to Sales (TTM) | 5.81 | 4.00 | 6.22 | |
| Price to Book (MRQ) | 8.29 | 5.02 | 5.20 | |
| Price to Tangible Book (MRQ) | 9.32 | 5.76 | 6.74 | |
| Price to Cash Flow (TTM) | -- | 23.20 | 24.17 | |
| % Owned Institutions | -- | 0.95 | 1.78 | |
Dividends
| Company | industry | sector | ||
|---|---|---|---|---|
| Dividend Yield | 1.98 | 1.55 | 1.44 | |
| Dividend Yield - 5 Year Avg | 1.74 | 1.56 | 1.46 | |
| Dividend 5 Year Growth Rate | 135.87 | 4.21 | 4.94 | |
| Payout Ratio(TTM) | 54.95 | 45.68 | 42.49 | |
Growth Rates
| Company | industry | sector | ||
|---|---|---|---|---|
| Sales (MRQ) vs Qtr. 1 Yr. Ago | 17.39 | 2.33 | 8.17 | |
| Sales (TTM) vs TTM 1 Yr. Ago | 20.84 | 4.80 | 6.50 | |
| Sales - 5 Yr. Growth Rate | 81.05 | 10.00 | 10.44 | |
| EPS (MRQ) vs Qtr. 1 Yr. Ago | 23.04 | 17.26 | 23.09 | |
| EPS (TTM) vs TTM 1 Yr. Ago | 31.02 | -- | -- | |
| EPS - 5 Yr. Growth Rate | 82.83 | 9.88 | 10.49 | |
| Capital Spending - 5 Yr. Growth Rate | 39.73 | 15.23 | 14.59 | |
Financial Strength
| Company | industry | sector | |
|---|---|---|---|
| Quick Ratio (MRQ) | 1.69 | 2.20 | 2.28 |
| Current Ratio (MRQ) | 1.84 | 3.02 | 3.10 |
| LT Debt to Equity (MRQ) | 0.00 | 8.89 | 11.49 |
| Total Debt to Equity (MRQ) | 3.15 | 12.69 | 16.03 |
| Interest Coverage (TTM) | -- | 35.18 | 30.57 |
Profitability Ratios
| Company | industry | sector | ||
|---|---|---|---|---|
| Gross Margin (TTM) | 83.25 | 54.41 | 54.44 | |
| Gross Margin - 5 Yr. Avg. | 84.42 | 51.86 | 52.36 | |
| EBITD Margin (TTM) | 23.40 | -- | -- | |
| EBITD - 5 Yr. Avg | 21.66 | 18.41 | 13.16 | |
| Operating Margin (TTM) | 23.47 | 14.42 | 6.07 | |
| Operating Margin - 5 Yr. Avg. | 19.31 | 14.55 | 8.47 | |
| Pre-Tax Margin (TTM) | 24.39 | 14.96 | 7.02 | |
| Pre-Tax Margin - 5 Yr. Avg. | 20.53 | 14.97 | 8.71 | |
| Net Profit Margin (TTM) | 20.97 | 11.16 | 3.12 | |
| Net Profit Margin - 5 Yr. Avg. | 17.58 | 11.23 | 4.91 | |
| Effective Tax Rate (TTM) | 14.03 | 23.45 | 23.26 | |
| Effective Tax Rate - 5 Yr. Avg. | 14.39 | 23.65 | 23.83 | |
Efficiency
| Company | industry | sector | ||
|---|---|---|---|---|
| Revenue/Employee (TTM) | 1,003,176 | 997,011,333 | 873,051,409 | |
| Net Income/Employee (TTM) | 210,358 | 118,232,370 | 103,483,755 | |
| Receivable Turnover (TTM) | 3.47 | 5.82 | 5.80 | |
| Inventory Turnover (TTM) | 4.77 | 2.68 | 3.56 | |
| Asset Turnover (TTM) | 1.08 | 0.99 | 0.95 | |
Management Effectiveness
| Company | industry | sector | ||
|---|---|---|---|---|
| Return on Assets (TTM) | 22.73 | 11.98 | 11.45 | |
| Return on Assets - 5 Yr. Avg. | 20.57 | 13.28 | 12.50 | |
| Return on Investment (TTM) | 31.21 | 15.55 | 14.96 | |
| Return on Investment - 5 Yr. Avg. | 30.33 | 17.28 | 16.23 | |
| Return on Equity (TTM) | 31.81 | 16.92 | 16.52 | |
| Return on Equity - 5 Yr. Avg. | 31.05 | 18.21 | 17.37 | |
| 1 Year | 3 Year | 5 Year | |
|---|---|---|---|
| Sales % | 24.15 | 24.10 | 81.05 |
| EPS (TTM) % | 33.17 | 21.07 | 82.83 |
| Dividend % | 4.29 | -- | 135.87 |
Note: Units in Millions of US Dollars
Performance for Hubei Jumpcan Pharmaceutical Co Ltd
Note:: Rank is a percentile that ranges from 0 to 99, with 99 = best.
Institutional Holders
| % Shares Owned: | 11.89% |
| # of Holders: | 65 |
| Total Shares Held: | 96,856,897 |
| 3 Mo. Net Change: | 1,404,707 |
| # New Positions: | 0 |
| # Closed Positions: | 3 |
| # Increased Positions: | 5 |
| # Reduced Positions: | 7 |
| # Net Buyers: | -2 |
NYSE and AMEX quotes delayed by at least 20 minutes. NASDAQ delayed by at least 15 minutes. For a complete list of exchanges and delays, please click here.